Company Protagenic Therapeutics, Inc. Other OTC
Equities
PTIX
US74365N1037
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/16/01 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/16/01 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/94/03 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/17/28 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01/07/01 |
Timothy Wright
BRD | Director/Board Member | 66 | 23/22/23 |
Jennifer Buell
BRD | Director/Board Member | 50 | 18/20/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.com![address Protagenic Therapeutics, Inc.(PTIX)](https://cdn.zonebourse.com/static/address/30379174.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |